Neuropsychological correlates of homocysteine levels in euthymic bipolar patients

Journal of Affective Disorders

Volumn 105, Issue 1-3, 2008, Pages 229-233

  Osher, Yamima ^a   Bersudsky, Yuly ^a   Silver, Henry ^b   Sela, Ben Ami ^c   Belmaker, R H ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b SHA'AR MENASHE MENTAL HEALTH CENTER   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Bipolar disorder; Folate; Homocysteine; Neuropsychology; Vitamin B 12

Indexed keywords

CARBAMAZEPINE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; LITHIUM CARBONATE; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR DISORDER; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PATIENT ASSESSMENT; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BIPOLAR DISORDER; COGNITION; COGNITION DISORDERS; DYSTHYMIC DISORDER; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; VITAMIN B 12;

EID: 37049003773     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.04.005     Document Type: Article

References (23)

1. Bell I.R., Edman J.S., Marby D.W., Satlin A., Dreier T., Liptzin B., and Cole J.O. Vitamin B12 and folate status in acute geropsychiatric inpatients: affective and cognitive characteristics of a vitamin nondeficient population. Biological Psychiatry 27 2 (1990) 125-137
2. Bolander-Gouaille C. Focus on Homocysteine (2000), Springer Verlag, France
3. Dittman S., Seemuller F., Schwarz M.J., Kleindienst N., Stampfer R., Zach J., Born C., Bernhard B., Fast K., Grunze H., Engel R.R., and Severus E. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results. Bipolar Disorders 9 (2007) 63-70
4. Elias M.F., Robbins M.A., Budge M.M., Elias P.K., Brennan S.L., Johnston C., Nagy Z., and Bates C.J. Homocysteine, folate, and vitamins B6 and B12 blood levels in relation to cognitive performance: the Maine-Syracuse study. Psychosomatic Medicine 68 (2006) 547-554
5. Fairbanks V.F., and Klee G.G. Biochemical aspects of hematology. In: Burtis C.A., and Ashwood E.R. (Eds). Tietz Textbook of Clinical Chemistry. 2nd ed. (1994), W.B. Saunders Co., Philadelphia 2046-2057
6. Ferrier I.N., Stanton B.R., Kelly T.P., and Scott J. Neuropsychological function in euthymic patients with bipolar disorder. British Journal of Psychiatry 175 (1999) 246-251
7. Frangou S., Haldane M., Roddy D., and Kumari V. Evidence for deficit in tasks of ventral, but not dorsal, prefrontal executive function as an endophenotypic marker for bipolar disorder. Biological Psychiatry 58 (2005) 838-839
8. Gilbody S., Lewis S., and Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. American Journal of Epidemiology 165 (2007) 1-13
9. Glahn D.C., Bearden C.E., Niendam T.A., and Escamilla M.A. The feasibility of neuropsychologial endophenotypes in the search for genes associated with bipolar affective disorder. Bipolar Disorders 6 (2004) 171-182
10. Kruman I.I., Culmsee C., Chan S.L., Kruman Y., Guo Z., Penix L., and Mattson M.P. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitoxicity. Journal of Neuroscience 20 (2000) 6920-6926
11. Levine J., Stahl Z., Sela B.A., Gavendo S., Ruderman V., and Belmaker R.H. Elevated homocysteine levels in young male patients with schizophrenia. American Journal of Psychiatry 159 10 (2002) 1790-1792
12. Levine J., Stahl Z., Sela B.-A., Ruderman V., Shumaico O., Babushkin I., Osher Y., Bersudsky Y., and Belmaker R.H. Homocysteine Reducing Strategies Improve Symptoms in Chronic Schizophrenic Patients with Hyperhomocysteinemia. Biological Psychiatry 60 (2006) 265-269
13. Lipton S.A., Kim W.-K., Choi Y.-B., Kumar S., D'Emilia D.M., Rayadu P.V., Arnelle D.R., and Stamler J.S. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proceedings of the National Academy of Sciences of the United States of America 94 (1997) 5923-5928
14. Lyoo I.K., Sung Y.H., Dager S.R., Friedman S.D., Lee J.Y., Kim S.J., Kim N., Dunner D.L., and Renshaw P.F. Regional cerebral cortical thinning in bipolar disorder. Bipolar Disorders 8 1 (2006) 65-74
15. Mooijaart S.P., Gussekloo J., Frolich M., Jolles J., Stott D.J., Westendorp R.G.J., and de Craen A.J.M. Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-plus study. American Journal of Clinical Nutrition 82 4 (2005) 866-871
16. Osher Y., Sela B.A., Levine J., and Belmaker R.H. Elevated homcysteine levels in euthymic bipolar disorder patients showing functional deterioration. Bipolar Disorders 6 (2004) 82-86
17. Reif A., Pfuhlmann B., and Lesch K.P. Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses. Progress in Neuro-Psychopharmacology & Biological Psychiatry 29 (2005) 1162-1168
18. Selhub J., Jacques P.F., Rosenberg I.H., Rogers G., Bowman B.A., Gunter E.W., Wright J.D., and Johnson C.L. Serum total homocysteine concentrations in the third national health and nutrition examination survey: population reference ranges and contribution of vitamin status to high serum concentrations. Annals of Internal Medicine 131 (1999) 331-339
19. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino B., Wilson P.W.F., and Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New England Journal of Medicine 346 (2002) 476-483
20. Stahl Z., Belmaker R.H., Friger M., and Levine J. Nutritional and life style determinants of plasma homocysteine in schizophrenia patients. European Journal of Neuropsychopharmacology 15 3 (2005) 291-295
21. Zalla T., Joyce C., Szoke A., Schurhoff F., Pillon B., Komano O., Perez-Diaz F., Bellivier F., Alter C., Dubois B., Rouillon F., Houde O., and Leboyer M. Executive dysfunctions as potential markers of familial vulnerabililty to bipolar disorder and schizophrenia. Psychiatry Research 121 (2004) 207-217
22. Zintzaras E. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies. Psychiatric Genetics 16 (2006) 105-115
23. Zubieta J.K., Huguelet P., O'Neil R.L., and Giordani B.J. Cognitive function in euthymic bipolar I disorder. Psychiatry Research 102 (2001) 9-20